July 5, 2019 8:43am
As session is stuck between a holiday and a weekend while futures slip and volume should be low
Pre-open Indications: NONE
As July’s first week ends – a short one interspersed with a holiday and volatility; low volume is the determinants as Q3 begins
The 6 W’s: Who, what, where, when, why and what of it … the real question is who is going to do what?
Dow futures are DOWN -0.20% (-56 points), S&P futures are DOWN -0.22% (-7 points) and also are NASDAQ futures DOWN -0.25% (-20 points)
Markets are slated to open slightly lower open as investors focused on the release of a key monthly jobs report;
European stocks traded lower with the pan-European Stoxx 600 slipping - 0.4% midway through the morning session;
Asia Pacific equities were muted;
Data docket: nonfarm payrolls and unemployment data, expected at 8:30 a.m. ET on Friday.
- Payroll growth rebounded sharply in June as the U.S. economy added 224,000 jobs amid concerns that both the employment picture and overall growth picture were beginning to weaken. The unemployment rate edged up to 3.7%.
Market focus is largely attuned to nonfarm payrolls and unemployment data.
Don’t expect a lot from the sector post a holiday and pre a weekend!
From Wednesday’s post “Monday’s cadre of my 45 covered companies closed to the downside with a negative Advance/Decline (A/D) line of 19/23, Tuesday closed again negative with a A/D line of 11/30 while Wednesday closed positive with an A/D line of 31/10.”
I also stated, “Markets are closed Thursday for Independence Day; independence but, not from volatility!”
The iShares NASDAQ Biotechnology (IBB) indicator: Monday closed up +0.58%, Tuesday was not reported. Wednesday closed up +1.17%, Thursday was a holiday while last Friday closed up +1.70%
Q3/19 so far:
- there were 1 positive, 1 holiday and 2 negative closes;
Companies in my headlights – It’s your decision; I provide an idea and context: post earnings release:
- holiday interruptus exists
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.